EUVIMEDEUVIMED entdecken
Crossref

In Situ Injectable Sequentially Responsive Hydrogel Based on Triblock Copolymers for Breast Cancer Theranostic Amplification

Yuxi Chen, Qiongxue Huang, Xueqiang Nie, Qingqin He, Jiawen Zhang, Tonghe Liu, Sichao Tian, Yihang Li, Zhaocui Sun iD, Zhonghao Sun, Guoxu Ma iD, Haitao Liu

Biomacromolecules · 2025

DOI: 10.1021/acs.biomac.5c00320 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomacromolecules, 2025. Verfasst von Yuxi Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education; Institute of Medicinal Plant Devel…. Hauptthemen laut MEDLINE: Hydrogels, Breast Neoplasms, Triterpenes, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences, Yunnan Key Laboratory of Southern Medicine Utilization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Celastrol (Cel), a natural small molecule, effectively inhibits breast cancer but has poor solubility and systemic toxicity. Herein, an in situ injectable sequentially responsive celastrol hydrogel (FCPC) based on the temperature-sensitive poloxamer F127 and tumor-acidity-cleavable maleic acid amide is rationally designed. Once injected into tumor tissue, FCPC forms a stable gel state rapidly, followed by continuously releasing activity molecules for five days. This injectable thermosensitive drug delivery system extends the drug residence time and targeted release. The platform greatly strengthens the Cel's antitumor ability both in vitro and in vivo and meanwhile reduces cancer metastasis and toxic side effects. Studies suggest FCPC may act by suppressing PI3K-Akt and MAPK pathways. Such an injectable sequentially responsive hydrogel intelligently solves the administration problem caused by poor solubility of natural small molecule and has the potential for clinical applicability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrogelsBreast NeoplasmsTriterpenesAntineoplastic AgentsFemaleHumansAnimalsMicePentacyclic TriterpenesPoloxamerDrug Delivery SystemsMice, Inbred BALB CCell Line, TumorMice, Nude

Substanzen

HydrogelsPentacyclic TriterpenescelastrolPoloxamerTriterpenesAntineoplastic Agents

Autor:innen und Institutionen

  • Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education; Institute of Medicinal Plant Development, Peking Union Medical College, Chinese Academy of Medical Scien…
  • Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan Branch, Institute of Medicinal Plant Development, Peking Union Medical College, Chinese Academy of Medical Sciences, Jinghong 666100, China.

ORCID-Profile: Zhaocui Sun, Guoxu Ma

Förderung

  • Chinese Academy of Medical Sciences
  • Yunnan Key Laboratory of Southern Medicine Utilization

Zitieren

APA

Chen, Y., Huang, Q., Nie, X., He, Q., Zhang, J., Liu, T., Tian, S., Li, Y., Sun, Z., Sun, Z., Ma, G., & Liu, H. (2025). In Situ Injectable Sequentially Responsive Hydrogel Based on Triblock Copolymers for Breast Cancer Theranostic Amplification. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c00320

Vancouver

Chen Y, Huang Q, Nie X, He Q, Zhang J, Liu T, et al. In Situ Injectable Sequentially Responsive Hydrogel Based on Triblock Copolymers for Breast Cancer Theranostic Amplification. Biomacromolecules. 2025. doi:10.1021/acs.biomac.5c00320

BibTeX
@article{Chen2025,
  author = {Chen, Yuxi and Huang, Qiongxue and Nie, Xueqiang and He, Qingqin and Zhang, Jiawen and Liu, Tonghe and Tian, Sichao and Li, Yihang and Sun, Zhaocui and Sun, Zhonghao and Ma, Guoxu and Liu, Haitao},
  title = {In Situ Injectable Sequentially Responsive Hydrogel Based on Triblock Copolymers for Breast Cancer Theranostic Amplification},
  journal = {Biomacromolecules},
  year = {2025},
  doi = {10.1021/acs.biomac.5c00320}
}
Kostenlos starten →